| Document |
Document Title |
|
WO/2021/065450A1 |
An active light sensitive or radiation sensitive resin composition which contains (A) an acid-decomposable resin, (B) a compound represented by general formula (b1), and (C) a compound represented by general formula (c1), wherein the rat...
|
|
WO/2021/060305A1 |
The present invention addresses the problem of providing a catalyst filling method which prevents deterioration of the catalyst performance in cases where a solid acid catalyst is used in a fixed-bed reactor through which a fluid passes....
|
|
WO/2021/036060A1 |
A process comprises the manufacture or preparation of fluorinated benzene, in particular monofluorobenzene, in a vapor-phase fluorination process. For example, the process can comprise a batch or continuous manufacture or preparation of ...
|
|
WO/2021/029395A1 |
A compound which has one or more halogen atoms and an unsaturated double bond. A method for producing an iodine-containing vinyl monomer, said method comprising: (a) a step for preparing an iodine-containing alcoholic substrate having a ...
|
|
WO/2021/017362A1 |
Provided is a dechlorination method of a chloro-substituted aromatic compound (R 1-X m) using copper as a catalyst, comprising using R 1-X m as a substrate, adding R 2(OH) n, an alkaline substance with a pH value greater than 7, and a co...
|
|
WO/2020/262134A1 |
The present invention addresses the problem of providing a purification method for an actinic ray-sensitive or radiation-sensitive resin composition which can be used to form a pattern in which defects are inhibited. The present inventio...
|
|
WO/2020/246566A1 |
Provided are: a main chain scission-type resist material that can satisfy roughness in particular; and a composition containing the same. In the main chain scission-type resist material, the principal agent is directly decomposed by bein...
|
|
WO/2020/243572A2 |
The present invention relates to antibodies against influenza neuraminidase, compositions containing the antibodies and methods of using the antibodies.
|
|
WO/2020/232256A1 |
Compounds are provided that are useful as immunomodulators. The compounds have the Formula (I) including stereoisomers and pharmaceutically acceptable salts thereof, wherein R1a, R1b, R1c, R1d, R2a, R2b, R3, R3a, R4, R6, R7, R8, A, Z, X1...
|
|
WO/2020/175495A1 |
Provided is a method for producing a salt by reacting M+X- with YH so as to generate XH and M+Y-, and then removing the generated XH so as to obtain M+Y-. M+X- is a salt of a cation represented by M+ and an anion represented by X-. M+Y- ...
|
|
WO/2020/164217A1 |
Disclosed is a process for the manufacture of fluoroaryl compounds and derivatives thereof, in particular of fluorobenzenes and derivatives thereof, and especially wherein said manufacture relates to an environmentally friendly productio...
|
|
WO/2020/162408A1 |
The present invention has the effect of making it possible to produce 1,1,1-trifluoro-2,2-bisarylethane efficiently by a simple procedure by condensing a mixture of fluoral and hydrogen fluoride with an aryl compound under anhydrous cond...
|
|
WO/2020/118564A1 |
Compounds are provided having the structure of Formula (I) : (I) or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, isotope, or salt thereof, wherein X1, X2, and R1 are as defined herein. Such compounds function as thyr...
|
|
WO/2020/114813A1 |
The invention relates to a process for the preparation of 5-bromo-1,3-dichloro-2-fluoro-benzene by diazotization and reduction of 6-bromo-2,4-dichloro-3-fluoro-aniline, which is obtained by bromination of 2,4-dichloro-3-fluoro-aniline, w...
|
|
WO/2020/079079A1 |
The present invention relates to co-crystals comprising levothyroxine and a dicarboxylic acid, preferably L-tartaric acid or oxalic acid, and processes for the preparation thereof. Furthermore, the invention relates to a pharmaceutical c...
|
|
WO/2019/245409A1 |
The invention relates to a method for producing halogen-polyfluorobenzenes, wherein the halogen is chlorine and/or bromine, by reacting potassium salts of polyfluorocarboxylic acids with perhalogenalkanes or bromine as halogenating agent...
|
|
WO/2019/189037A1 |
Provided is a fused-ring compound which exhibits excellent charge transport capacity. This fused-ring compound is represented by formula (1) having a specific structure.
|
|
WO/2019/163395A1 |
This porous carbon material has a specific resistance value of 10 to 10,000 Ω·cm at a packing density of 0.4 g/cc.
|
|
WO/2019/159596A1 |
Provided is a method for preparing a coupled body represented by general formula (3), the coupled body being obtained by reacting a compound represented by general formula (1) and a compound represented by general formula (2) in the pres...
|
|
WO/2019/150327A1 |
An opto-electronic device includes a substrate, a first electrode disposed over the substrate, a semiconducting layer disposed over the first electrode, a second electrode disposed over the semiconducting layer, the second electrode havi...
|
|
WO/2019/147934A1 |
A method of treating Parkinson's Disease, Huntington's Disease and the like, diseases with abnormal dopamine-neurotransmission, using small molecules administered systemically that penetrate into the central nervous system to inhibit the...
|
|
WO/2019/143299A1 |
The present invention relates to hyper-branched compounds, a method of synthesizingthe hyper-branched compounds and applications of the hyper-branched compounds. Thehyper-branched compounds of the present invention include hyper-branched...
|
|
WO/2019/118768A1 |
A method to increase the efficiency of myotube generation and maturation from pluripotent stem cells comprising: (a) differentiating pluripotent stem cells to myogenic progenitors; and (b) terminally differentiating said myogenic progeni...
|
|
WO/2019/108773A1 |
The present invention relates to substituted stilbenes and dienones which exhibit unexpected dual activity, as inhibitors of NFκB and as agonists (activators) of Nrf2. In particular, these compounds show dual activity and makes them par...
|
|
WO/2019/083997A1 |
The present disclosure relates to compounds that bind to flavin-containing enzymes and inhibit mitochondrial function, referred to herein as mitoflavoscins. Methods of screening compounds for mitochondrial inhibition and anti-cancer prop...
|
|
WO/2019/079609A1 |
Provided herein are novel bioavailable dual inhibitors capable of inhibiting both soluble epoxide hydrolase (sEH) and phosphodiesterase 4 (PDE4), and methods of using the same.
|
|
WO/2019/052236A1 |
The present invention pertains to the field of fine chemicals and related chemical technologies and provides a preparation method for a butadiene derivative. Phenylacetylene and derivatives thereof are used as raw materials and react in ...
|
|
WO/2019/039759A1 |
The present invention relates to a method for producing mono-iodobenzene and mono-iodobenzene produced therefrom, the method enabling the selective recovery of gas-state iodine that is lost when regenerating a catalyst used in a reaction...
|
|
WO/2019/031743A1 |
The present specification provides a method for preparing a styrene monomer, comprising, as a step of preparing a styrene monomer of chemical formula 2 by reacting a compound represented by chemical formula 1 in the presence of phosphori...
|
|
WO/2019/004021A1 |
The purpose of the present invention is to control the alignment of liquid crystal molecules of a liquid crystal display element not having an alignment film, by using a non-colored alignment-control-layer-forming monomer, and to provide...
|
|
WO/2018/225087A1 |
The present invention discloses a cobalt compound of formula (I), a process for the preparation and use thereof. The present invention further relates to a pharmaceutical composition and a method inhibition of Tau Aggregation in a subjec...
|
|
WO/2017/192564A8 |
Disclosed is a fluorination method comprising providing an aryl fluorosuifonate and a fluorinating reagent to a reaction mixture; and reacting the aryl fluorosuifonate and the fluorinating reagent to provide a fluorinated aryl species. A...
|
|
WO/2018/179482A1 |
The purpose of the present invention is to provide an organic electroluminescence element which has a long life and emits blue light having high color purity. A dibenzo[c, g]fluorene compound including a specific substitution group of th...
|
|
WO/2018/178439A1 |
The invention relates to a method for the synthesis of 9,10-Bis(chloromethyl)anthracene, comprising the mixing of the reagents, anthracene and 1,3,5-Trioxane, a phase transfer catalyst selected from the group comprising quarternary ammon...
|
|
WO/2018/159427A1 |
This two-phase reaction medium for an organic reaction includes: a first liquid phase which uses 1,1,1,3,3,3-hexafluoropropan-2-ol (HFIP) as a solvent; and a second liquid phase comprising a solvent that is essentially incompatible with ...
|
|
WO/2018/151152A1 |
The present invention has successfully synthesized a carbon nanobelt represented by general formula (1) through chemical synthesis. [In the formula, each Ar may be the same or different and denotes an aromatic hydrocarbon ring; each R1 m...
|
|
WO/2018/146200A1 |
The present invention relates compounds useful as reagents for the diazomethylation reaction, their preparation and the use thereof as reagents in a method for the diazomethylation reaction of aromatic substrates. It relates in particula...
|
|
WO/2018/114914A1 |
The present invention relates to a method for producing (functionalized) biaryls by employing a visible-light-driven, gold-catalyzed C-C cross-coupling reaction system involving boron- and silicon-containing aryl compounds and aryldiazon...
|
|
WO/2018/102488A1 |
The present invention features methods, compositions, and kits for the treatment of all forms of emotional and painful symptoms related to the menstrual cycle, including symptoms characteristic of menstrual cycle-related disorders, such ...
|
|
WO/2018/087064A1 |
The invention relates to a method for producing triarylorganoborates from organoboronic acid esters in the presence of an n-valent cation 1/n Kn+, comprising the anhydrous treatment of the reaction mixture, and to the use of the obtained...
|
|
WO/2018/066371A1 |
The purpose of the present invention is to provide a process for producing an E-olefin compound, the process being capable of using a wide range of Z-olefin compounds as substrates. The process, which is for producing an isomer, comprise...
|
|
WO/2018/061677A1 |
Provided are: an industrially useful substituted bis(trifluorovinyl)benzene compound having excellent thermal stability; and a method for producing the same. A substituted bis(trifluorovinyl)benzene compound represented by general formul...
|
|
WO/2018/054877A1 |
The invention relates to a method for producing bistolanes which are substituted in the 1,1 '-position with halogen and to products from said compounds. The C-C-triple bonds of the bistolanes are produced by elimination reactions.
|
|
WO/2018/019436A1 |
The present invention relates to a process for preparing a partially hydrogenated polyacene, and a novel intermediate used in such process; also the present invention relates to a process for preparing the corresponding conjugated polyac...
|
|
WO/2018/009861A1 |
The present invention provides fluorescent polyfluorene polymers or macromers with unique optical properties that are stable. The polymeric fluorophores are useful in various bioassays formats. The inventive polymers are useful in assays...
|
|
WO/2017/008136A3 |
The present invention relates to fluorine substituted CBD compounds, compositions thereof and uses thereof for the preparation of medicaments.
|
|
WO/2017/192564A1 |
Disclosed is a fluorination method comprising providing an aryl fluorosuifonate and a fluorinating reagent to a reaction mixture; and reacting the aryl fluorosuifonate and the fluorinating reagent to provide a fluorinated aryl species. A...
|
|
WO/2017/163262A4 |
The present invention disclosed an improved one pot, one step process for halogenation of compound of formula (II) to afford corresponding halogenated compound of formula (I) having improved yield and increased selectivity under very mil...
|
|
WO/2017/188297A1 |
Provided is a resist composition that improves acid generation efficiency and is used to produce a photoresist having high sensitivity, high resolution, and high LWR properties. The present invention relates to a compound represented by ...
|
|
WO/2017/187859A1 |
The present invention is a compound represented by formula (1), a liquid crystal composition containing the compound, and a liquid crystal display element including the composition. In the formula: R is a C1-15 alkyl or the like; ring A1...
|
